PacBio, RainDance Technologies Partner to Commercialize Whole-Genome Assembly Solution | GenomeWeb

NEW YORK (GenomeWeb) – Pacific Biosciences and RainDance Technologies plan to co-develop and commercialize solutions for de novo whole-genome assembly, the companies said today.

The solutions will combine RainDance's digital droplet technology and single-molecule barcoding technology with PacBio's proprietary long-range DNA amplification technology to provide a sample prep solution that can be used prior to sequencing on the PacBio RS II.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.